Smith & Nephew PLC
SNN27.000USD
+0.480+1.81%
Horário de mercado （ET）Cotações atrasadas em 15 min
11.79BValor de mercado
--P/L TTM
Mais detalhes de Smith & Nephew PLC Empresa
Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Informações da empresa
Código da empresaSNN
Nome da EmpresaSmith & Nephew PLC
Data de listagemAug 13, 1951
Fundado em1937
CEOMr. Deepak S. Nath
Número de funcionários17349
Tipo de títulosEquity Future
Fim do ano fiscalAug 13
EndereçoBuilding 5
CidadeWATFORD
Bolsa de valoresJohannesburg Stock Exchange
PaísUnited Kingdom
Código postalWD18 8YE
Telefone4401923477100
Sitehttps://www.smith-nephew.com/
Código da empresaSNN
Data de listagemAug 13, 1951
Fundado em1937
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Marc E. Owen
Mr. Marc E. Owen
Non-Executive Independent Director
Non-Executive Independent Director
8.60K
+2.06%
Mr. Bob White
Mr. Bob White
Non-Executive Independent Director
Non-Executive Independent Director
4.19K
+6.56%
Ms. Alison Parkes
Ms. Alison Parkes
Chief Compliance Officer
Chief Compliance Officer
3.61K
-22.82%
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
1.82K
+34.44%
Mr. Paul Connolly
Mr. Paul Connolly
President - Global Operations
President - Global Operations
1.81K
+34.67%
Mr. Mizanu Kebede
Mr. Mizanu Kebede
Chief Quality and Regulatory Affairs Officer
Chief Quality and Regulatory Affairs Officer
1.14K
+10.42%
Mr. John Ma
Mr. John Ma
Non-Executive Independent Director
Non-Executive Independent Director
1.07K
+42.27%
Mr. Scott Schaffner
Mr. Scott Schaffner
President - Sports Medicine
President - Sports Medicine
809.00
+47.90%
Mr. Craig Gaffin
Mr. Craig Gaffin
President - Orthopaedics
President - Orthopaedics
490.00
+1.94K%
Mr. Jeremy Kim (Jez) Maiden
Mr. Jeremy Kim (Jez) Maiden
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Marc E. Owen
Mr. Marc E. Owen
Non-Executive Independent Director
Non-Executive Independent Director
8.60K
+2.06%
Mr. Bob White
Mr. Bob White
Non-Executive Independent Director
Non-Executive Independent Director
4.19K
+6.56%
Ms. Alison Parkes
Ms. Alison Parkes
Chief Compliance Officer
Chief Compliance Officer
3.61K
-22.82%
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
1.82K
+34.44%
Mr. Paul Connolly
Mr. Paul Connolly
President - Global Operations
President - Global Operations
1.81K
+34.67%
Mr. Mizanu Kebede
Mr. Mizanu Kebede
Chief Quality and Regulatory Affairs Officer
Chief Quality and Regulatory Affairs Officer
1.14K
+10.42%
Detalhamento da receita
Moeda: USDTempo de atualização: dom, 6 de abr
Moeda: USDTempo de atualização: dom, 6 de abr
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Sports Medicine Joint Repair
982.00M
16.90%
Knee Implants
947.00M
16.30%
Advanced Wound Care
735.00M
12.65%
Arthroscopic Enabling Technologies
632.00M
10.88%
Hip Implants
619.00M
10.65%
Other
1.90B
32.62%
Por RegiãoUSD
Nome
Receita
Proporção
United States of America
3.12B
53.75%
Other Established Markets
1.27B
21.88%
Emerging &internatiuonal market
980.00M
16.87%
United Kingdom
226.00M
3.89%
China
210.00M
3.61%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Sports Medicine Joint Repair
982.00M
16.90%
Knee Implants
947.00M
16.30%
Advanced Wound Care
735.00M
12.65%
Arthroscopic Enabling Technologies
632.00M
10.88%
Hip Implants
619.00M
10.65%
Other
1.90B
32.62%
Acionista
Tempo de atualização: sex, 21 de fev
Tempo de atualização: sex, 21 de fev
Estatísticas dos acionistas
Tipo
Estatísticas dos acionistas
Acionista
Proporção
Fiduciary Management, Inc.
0.91%
Millennium Management LLC
0.78%
Barrow Hanley Global Investors
0.48%
Scharf Investments, LLC
0.47%
River Road Asset Management, LLC
0.46%
Other
96.89%
Estatísticas dos acionistas
Acionista
Proporção
Fiduciary Management, Inc.
0.91%
Millennium Management LLC
0.78%
Barrow Hanley Global Investors
0.48%
Scharf Investments, LLC
0.47%
River Road Asset Management, LLC
0.46%
Other
96.89%
Tipo
Acionista
Proporção
Investment Advisor
4.55%
Hedge Fund
1.57%
Investment Advisor/Hedge Fund
1.08%
Research Firm
0.37%
Family Office
0.22%
Family Office
0.17%
Family Office
0.17%
Private Equity
0.10%
Pension Fund
0.06%
Other
91.71%
Participação acionária institucional
Tempo de atualização: seg, 20 de jan
Tempo de atualização: seg, 20 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q1
451
34.23M
7.82%
-10.03M
2024Q4
454
34.98M
8.00%
-9.87M
2024Q3
442
33.73M
7.72%
-17.08M
2024Q2
451
37.69M
8.62%
-9.14M
2024Q1
460
34.95M
7.99%
-8.57M
2023Q4
456
32.65M
7.47%
-10.09M
2023Q3
451
40.30M
9.23%
-2.29M
2023Q2
453
39.60M
9.07%
-7.09M
2023Q1
461
43.45M
9.95%
-3.75M
2022Q4
459
43.39M
9.94%
-3.85M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Fiduciary Management, Inc.
4.00M
0.91%
-233.06K
-5.51%
Dec 31, 2024
Millennium Management LLC
3.43M
0.78%
+3.43M
--
Dec 31, 2024
Barrow Hanley Global Investors
2.10M
0.48%
-1.84M
-46.70%
Dec 31, 2024
Scharf Investments, LLC
2.63M
0.6%
-268.93K
-9.27%
Dec 31, 2024
River Road Asset Management, LLC
2.03M
0.46%
+792.83K
+63.98%
Dec 31, 2024
J. Goldman & Co., L.P.
1.94M
0.44%
+1.94M
--
Dec 31, 2024
Brandes Investment Partners, L.P.
1.36M
0.31%
+138.99K
+11.36%
Dec 31, 2024
Parametric Portfolio Associates LLC
1.32M
0.3%
+197.28K
+17.57%
Dec 31, 2024
Goldman Sachs Asset Management, L.P.
894.41K
0.2%
-104.78K
-10.49%
Dec 31, 2024
The Clark Estates Inc.
800.00K
0.18%
+115.00K
+16.79%
Dec 31, 2024
Ver Mais
ETFs Relacionados
Tempo de atualização: dom, 6 de abr
Tempo de atualização: dom, 6 de abr
Nome
Proporção
Brandes International ETF
2.2%
ALPS Disruptive Technologies ETF
1.17%
ActivePassive International Equity ETF
0.13%
SPDR S&P Kensho New Economies Composite ETF
0.11%
SP Funds S&P World (ex-US) ETF
0.08%
Avantis Responsible International Equity ETF
0.07%
Avantis International Equity ETF
0.06%
DFA Dimensional International Core Equity 2 ETF
0.04%
Goldman Sachs MarketBeta Total Internatl Eqty ETF
0%
First Trust BuyWrite Income ETF
0%
Ver Mais
Brandes International ETF
Proporção2.2%
ALPS Disruptive Technologies ETF
Proporção1.17%
ActivePassive International Equity ETF
Proporção0.13%
SPDR S&P Kensho New Economies Composite ETF
Proporção0.11%
SP Funds S&P World (ex-US) ETF
Proporção0.08%
Avantis Responsible International Equity ETF
Proporção0.07%
Avantis International Equity ETF
Proporção0.06%
DFA Dimensional International Core Equity 2 ETF
Proporção0.04%
Goldman Sachs MarketBeta Total Internatl Eqty ETF
Proporção0%
First Trust BuyWrite Income ETF
Proporção0%
Dividendo
Um total de
1.64B
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Feb 26, 2025
SNN.NB Approximate interim Cash Dividend of gross USD 0.462 paid on May 28, 2025 going ex on Mar 28, 2025
Mar 28, 2025
May 28, 2025
Mar 28, 2025
Sep 24, 2024
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Nov 08, 2024 going ex on Oct 04, 2024
Oct 04, 2024
Nov 08, 2024
Oct 04, 2024
Mar 04, 2024
SNN.NB Interim Cash Dividend of gross USD 0.462 paid on May 22, 2024 going ex on Apr 01, 2024
Apr 02, 2024
May 22, 2024
Apr 01, 2024
Aug 03, 2023
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Nov 01, 2023 going ex on Oct 05, 2023
Oct 06, 2023
Nov 01, 2023
Oct 05, 2023
Feb 27, 2023
SNN.NB Interim Cash Dividend of gross USD 0.462 paid on May 17, 2023 going ex on Mar 30, 2023
Mar 31, 2023
May 17, 2023
Mar 30, 2023
Jul 29, 2022
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Oct 26, 2022 going ex on Sep 29, 2022
Sep 30, 2022
Oct 26, 2022
Sep 29, 2022
Mar 14, 2022
SNN.NB Interim Cash Dividend of gross USD 0.462 paid on May 11, 2022 going ex on Mar 31, 2022
Apr 01, 2022
May 11, 2022
Mar 31, 2022
Aug 12, 2021
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Oct 27, 2021 going ex on Sep 30, 2021
Oct 01, 2021
Oct 27, 2021
Sep 30, 2021
Feb 19, 2021
SNN.NB Final Cash Dividend of gross USD 0.462 paid on May 12, 2021 going ex on Apr 05, 2021
Apr 06, 2021
May 12, 2021
Apr 05, 2021
Jul 29, 2020
SNN.NB Interim Cash Dividend of gross USD 0.288 paid on Oct 28, 2020 going ex on Oct 01, 2020
Oct 02, 2020
Oct 28, 2020
Oct 01, 2020
Ver Mais
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados